Bullfrog AI (NASDAQ:BFRG – Get Free Report) released its earnings results on Friday. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.02), FiscalAI reports. The firm had revenue of $0.06 million during the quarter, compared to analysts’ expectations of $0.21 million.
Bullfrog AI Price Performance
Shares of NASDAQ:BFRG traded down $0.01 on Friday, hitting $0.54. 92,414 shares of the company’s stock were exchanged, compared to its average volume of 5,027,272. The stock has a market capitalization of $10.04 million, a price-to-earnings ratio of -1.18 and a beta of -2.60. Bullfrog AI has a 12 month low of $0.43 and a 12 month high of $1.96. The business’s 50 day simple moving average is $0.55 and its two-hundred day simple moving average is $0.64.
Insider Transactions at Bullfrog AI
In related news, CFO Joshua Blacher purchased 50,000 shares of Bullfrog AI stock in a transaction that occurred on Tuesday, September 22nd. The shares were bought at an average price of $0.53 per share, with a total value of $26,500.00. Following the purchase, the chief financial officer directly owned 65,000 shares of the company’s stock, valued at approximately $34,450. This represents a 333.33% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Vininder Singh purchased 75,000 shares of Bullfrog AI stock in a transaction that occurred on Tuesday, September 22nd. The stock was bought at an average cost of $0.60 per share, for a total transaction of $45,000.00. Following the purchase, the chief executive officer directly owned 2,442,446 shares in the company, valued at $1,465,467.60. This trade represents a 3.17% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 14.70% of the company’s stock.
Analyst Ratings Changes
Separately, Weiss Ratings raised Bullfrog AI from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, October 2nd. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.
Read Our Latest Report on BFRG
Bullfrog AI Company Profile
BullFrog AI Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine. Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.
Read More
- Five stocks we like better than Bullfrog AI
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.
